Live Stocks are getting hit again as Trump lashes out at the Fed and Powell. See the latest. OTC Markets OTCPK - Delayed Quote • USD Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Follow Compare 1.5620 -0.0080 (-0.51%) As of April 17 at 4:00:00 PM EDT. Market Open. All News Press Releases SEC Filings HUTCHMED to Divest 45% Equity Stake in Shanghai Hutchison Pharmaceuticals for $608 Million HUTCHMED (HCM) said Wednesday it has agreed to sell a 45% equity interest in Shanghai Hutchison Phar HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture — HUTCHMED continues to deliver on its strategy outlined in November 2022 to create value, prioritize its portfolio and bring innovative medicines to patients globally — — Divestment proceeds to advance HUTCHMED’s pipeline and core innovative medicines business — — Focused R&D investment includes HUTCHMED’s proprietary antibody-targeted therapy conjugate platform, with first candidates expected to enter clinical trials in the second half of 2025 — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., J Performance Overview Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) Return SHPMF SSE Composite Index (000001.SS) YTD -4.76% -1.80% 1-Year +35.81% +7.38% 3-Year +15.90% +6.87%